Article
Survival difference between high-risk and low-risk CFTR genotypes after lung transplant.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation - 1 Oct 2022
Clausen Emily S, Weber Jeremy M, Neely Megan L, Ramos Kathleen J, Snyder Laurie D
Abstract excerpt
BACKGROUND: While cystic fibrosis transmembrane conductance regulator (CFTR) genotypes are associated with clinical outcomes in cystic fibrosis patients, it is unknown if genotype impacts lung transplant outcomes. We sought to compare lung transplant survival and time to bronchiolitis obliterans syndrome (BOS) between high-risk, low-risk, and not yet classified CFTR genotypes. METHODS: We used merged data from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
